{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:23:22Z","timestamp":1773379402680,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004431","name":"Commission europ\u00e9enne Direction G\u00e9n\u00e9rale de la Recherche et de l'Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"French National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018001","name":"Soci\u00e9t\u00e9 Fran\u00e7aise de lutte contre les Cancers et les leuc\u00e9mies de l'Enfant et de l'Adolescent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jhep.2025.05.005","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T19:38:42Z","timestamp":1747856322000},"page":"286-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immune exclusion in hepatoblastoma: Is \u03b2-catenin to blame again?"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4428-2997","authenticated-orcid":false,"given":"Theo Z.","family":"Hirsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2025.05.005_bib1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","article-title":"Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children\u2019s Hepatic tumors International Collaboration","volume":"18","author":"Meyers","year":"2017","journal-title":"The Lancet Oncol"},{"key":"10.1016\/j.jhep.2025.05.005_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.113583","article-title":"Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival","volume":"200","author":"Pire","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jhep.2025.05.005_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102446","article-title":"The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solution","volume":"69","author":"O\u2019Neill","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.jhep.2025.05.005_bib4","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"The New Engl J Med"},{"key":"10.1016\/j.jhep.2025.05.005_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-02828-8","article-title":"Immunotherapy at all stages of hepatocellular carcinoma","author":"Pinato","year":"2024","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jhep.2025.05.005_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jhep.2025.01.031","article-title":"Multiomic analysis uncovers a continuous spectrum of differentiation and Wnt-MDK-driven immune evasion in hepatoblastoma","volume":"83","author":"M\u00fcnter","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.005_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41420-023-01392-3","article-title":"Midkine inhibition enhances anti-PD-1 immunotherapy in sorafenib-treated hepatocellular carcinoma via preventing immunosuppressive MDSCs infiltration","volume":"9","author":"Ding","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.jhep.2025.05.005_bib8","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jhep.2021.06.023","article-title":"Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer","volume":"75","author":"Zhang","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.005_bib9","first-page":"269","article-title":"Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene","volume":"59","author":"Koch","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2025.05.005_bib10","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1158\/2159-8290.CD-20-1809","article-title":"Integrated genomic analysis identifies driver genes and cisplatin-resistant progenitor phenotype in pediatric liver cancer","volume":"11","author":"Hirsch","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2025.05.005_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1583547","article-title":"APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures","volume":"8","author":"Morcrette","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jhep.2025.05.005_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo5570","article-title":"Immunogenomic cancer evolution: a framework to understand cancer immunosuppression","volume":"10","author":"Kumagai","year":"2025","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jhep.2025.05.005_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2025.05.005_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc6424","article-title":"Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape","volume":"6","author":"Takeuchi","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jhep.2025.05.005_bib15","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.06.007","article-title":"Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2025.05.005_bib16","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","article-title":"\u03b2-Catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma","volume":"9","author":"Ruiz de Galarreta","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2025.05.005_bib17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jhep.2022.03.015","article-title":"Unique molecular characteristics of NAFLD-associated liver cancer accentuate \u03b2-catenin\/TNFRSF19-mediated immune evasion","volume":"77","author":"Wong","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.05.005_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/08880018.2020.1853859","article-title":"Complete and durable response to immune checkpoint inhibitor in a patient with refractory and metastatic hepatoblastoma","volume":"38","author":"Tsai","year":"2021","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jhep.2025.05.005_bib19","article-title":"Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers","author":"Steffin","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2025.05.005_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-024-08452-3","article-title":"Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas","author":"Monje","year":"2024","journal-title":"Nature"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825022032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825022032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T21:12:35Z","timestamp":1773349955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827825022032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0168827825022032"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.05.005","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune exclusion in hepatoblastoma: Is \u03b2-catenin to blame again?","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.01.031","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}